Successful Results of Phase 1 Clinical Trial
Filed with ASX · · 4 pages · English
Underwood Capital Limited on 6ix
Earlier from Underwood Capital
Later from Underwood Capital
- Cannabis Legalisation Gives MMJ the Green Light
- Capital Raising
- Satipharm Gelpell Outperforms Sativex in Phase 1 Trial
- Progress on MMJs Lucky Lake Facility MMPR Application
- MMJ Marks AUS Market Entry with Two Strategic Partnerships
Follow Underwood Capital into a list and get an email when it puts out news.
Follow Underwood Capital